Terns Pharmaceuticals, Inc.TERNNASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
10.42%
↓ 81% below average
Average (6y)
53.90%
Historical baseline
Range
High:322.80%
Low:-54.45%
Volatility
699.9%
High variability
| Period | Value |
|---|---|
| 2024 | 10.42% |
| 2023 | 60.28% |
| 2022 | 26.53% |
| 2021 | 11.71% |
| 2020 | -54.45% |
| 2019 | 322.80% |
| 2018 | 0.00% |